Clinical Trial: TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07825688) titled 'TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function' on Sept. 08.

Brief Summary: This is a prospective multicenter nonrandomized pragmatic hybrid effectiveness-implementation study to test the effectiveness of TxAccess in improving time to renal recovery and immunologic outcomes in patients with delayed graft function (DGF) and to assess barriers and facilitators to implementation of TxAccess in the post-transplant care period. Research blood will be collected for donor-derived cell-free DNA testing, and patient questionnaires will be administered.

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL...